Positive MAP Insights
Note that this consultation has been extended by several days from the original closing date of 20th Jan 2020, and will now close on the 31st January 2020.
Canada’s Patented Medicine Prices Review Board (PMPRB) has launched a consultation on its new Guidelines including changes for both grandfathered and non-grandfathered medicines.
The consultation follows the announcement of new Patented Medicines Regulations, coming into effect from 1st July 2020, which, as MAP reported in August, will alter conditions such as which countries Canada may use for international reference pricing (IRP).
To complement written submissions, PMPRB says:
“The PMPRB will be travelling during the week of December 2nd to meet with various stakeholders in:
- Victoria and Vancouver, British Columbia
- Edmonton, Alberta
- Regina, Saskatchewan
- Winnipeg, Manitoba
If you are interested in meeting with PMPRB officials to discuss the proposed guidelines, please send an email to PMPRB.Consultations.CEPMB@pmprb-cepmb.gc.ca“
PMPRB provides an extensive “backgrounder” into the consultation, as well as the full set of draft Guidelines for consideration. Responses should be provided to PMPRB.Consultations.CEPMB@pmprb-cepmb.gc.ca before 31st January 2020.